These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 33476583)

  • 1. COVID-19 vaccine prioritisation for type 1 and type 2 diabetes.
    Powers AC; Aronoff DM; Eckel RH
    Lancet Diabetes Endocrinol; 2021 Mar; 9(3):140-141. PubMed ID: 33476583
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-19 vaccine prioritisation for people with disabilities.
    Epstein S; Ayers K; Swenor BK
    Lancet Public Health; 2021 Jun; 6(6):e361. PubMed ID: 33894137
    [No Abstract]   [Full Text] [Related]  

  • 3. Coronavirus vaccine? Join the queue.
    The Lancet Diabetes Endocrinology
    Lancet Diabetes Endocrinol; 2021 Jan; 9(1):1. PubMed ID: 33285121
    [No Abstract]   [Full Text] [Related]  

  • 4. COVID-19 Vaccine: Promoting Vaccine Acceptance.
    Laine C; Cotton D; Moyer DV
    Ann Intern Med; 2021 Feb; 174(2):252-253. PubMed ID: 33347321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDA authorizes Pfizer-BioNTech COVID-19 vaccine.
    Med Lett Drugs Ther; 2021 Jan; 63(1615):1-2. PubMed ID: 33646996
    [No Abstract]   [Full Text] [Related]  

  • 6. Is It Lawful and Ethical to Prioritize Racial Minorities for COVID-19 Vaccines?
    Schmidt H; Gostin LO; Williams MA
    JAMA; 2020 Nov; 324(20):2023-2024. PubMed ID: 33052391
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA authorizes Moderna COVID-19 vaccine.
    Med Lett Drugs Ther; 2021 Jan; 63(1616):9-10. PubMed ID: 33512345
    [No Abstract]   [Full Text] [Related]  

  • 8. Tackling inequitable distribution of the COVID-19 vaccine.
    Mendes A
    Br J Community Nurs; 2021 Jan; 26(1):48-49. PubMed ID: 33356933
    [No Abstract]   [Full Text] [Related]  

  • 9. Rethinking the Current Older-people-first Policy for COVID-19 Vaccination in Japan.
    Matsui K; Inoue Y; Yamamoto K
    J Epidemiol; 2021 Sep; 31(9):518-519. PubMed ID: 34148916
    [No Abstract]   [Full Text] [Related]  

  • 10. [Defining priorities, the case of of COVID-19 vaccine].
    Frigerio M
    G Ital Cardiol (Rome); 2021 Jun; 22(6):509-510. PubMed ID: 34037597
    [No Abstract]   [Full Text] [Related]  

  • 11. Should people with severe mental illness be prioritized for the COVID-19 vaccination?
    Yang Y; Li W; Zhang Q; Zhang L; Cheung T; Ng CH; Xiang YT
    Int J Biol Sci; 2021; 17(6):1443-1445. PubMed ID: 33907507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cultural competence in vaccine rollout: migrants would face difficulties accessing covid-19 vaccines.
    Waterman LZ
    BMJ; 2021 Jan; 372():n220. PubMed ID: 33500270
    [No Abstract]   [Full Text] [Related]  

  • 13. COVID-19 vaccine prioritisation for people with cystic fibrosis.
    Carr SB; Cosgriff R; Harutyunyan S; Middleton PG; Ruseckaite R; Ahern S; Daneau G; Filho LVRFDS; Stephenson AL; Cheng SY; Melo J; Corvol H; Burgel PR; Nährlich L; McKone E; Colombo C; Salvatore M; Padoan R; Abdrakhmanov O; Gulmans V; Byrnes CA; Amelina E; Kondratyeva E; Zhekayte E; Kashirskaya N; Zampoli M; Pastor-Vivero MD; Mondejar-Lopez P; de Monestrol I; Jung A; McClenaghan E; Brownlee K; Rizvi S; Goss CH; Elbert A; Faro A; Gutierrez H; Marshall BC
    J Cyst Fibros; 2021 Jul; 20(4):715-716. PubMed ID: 33941502
    [No Abstract]   [Full Text] [Related]  

  • 14. COVID-19 case profile is changing with the vaccine.
    Flahault A
    Anaesth Crit Care Pain Med; 2021 Apr; 40(2):100851. PubMed ID: 33771751
    [No Abstract]   [Full Text] [Related]  

  • 15. COVID-19 Vaccine and Biologics: An Impending Dilemma.
    Hauptman M; Vasic J; Krase J
    J Drugs Dermatol; 2021 Jan; 20(1):115-114. PubMed ID: 33400405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Who should be vaccinated first? Comparing vaccine prioritization strategies in Israel and European countries using the Covid-19 Health System Response Monitor.
    Cylus J; Panteli D; van Ginneken E
    Isr J Health Policy Res; 2021 Feb; 10(1):16. PubMed ID: 33608023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Building Trust in COVID-19 Vaccines and Beyond Through Authentic Community Investment.
    Ojikutu BO; Stephenson KE; Mayer KH; Emmons KM
    Am J Public Health; 2021 Mar; 111(3):366-368. PubMed ID: 33301352
    [No Abstract]   [Full Text] [Related]  

  • 18. The disproportionate excess mortality risk of COVID-19 in younger people with diabetes warrants vaccination prioritisation.
    McGovern AP; Thomas NJ; Vollmer SJ; Hattersley AT; Mateen BA; Dennis JM
    Diabetologia; 2021 May; 64(5):1184-1186. PubMed ID: 33594475
    [No Abstract]   [Full Text] [Related]  

  • 19. Preparing for COVID-19 vaccine roll-out through simulation exercises.
    Copper FA; de Vázquez CC; Bell A; Mayigane LN; Vedrasco L; Chungong S
    Lancet Glob Health; 2021 Jun; 9(6):e742-e743. PubMed ID: 33675693
    [No Abstract]   [Full Text] [Related]  

  • 20. An African plan to control COVID-19 is urgently needed.
    The Lancet
    Lancet; 2020 Dec; 396(10265):1777. PubMed ID: 33278920
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.